feed,title,long_url,short_url
Benzinga,Filsuvez's European Approval Adds Growth Driver For Amryt Pharma,https://benzinga.com/analyst-ratings/analyst-color/22/06/27846420/fulsuvezs-european-approval-adds-growth-driver-for-amryt-pharma,https://bit.ly/3u2Y9iW
Benzinga,Intellia's Gene-Editing Candidate Shows Durability In ATTR Amyloidosis,https://benzinga.com/general/biotech/22/06/27845289/intellias-gene-editing-candidate-shows-durability-in-attr-amyloidosis,https://bit.ly/3yj3ODX
